(Q47323865)

14 January 2018

title

Analysis of HER2 and HER4 in human myocardium to clarify the cardiotoxicity of trastuzumab (Herceptin). (English)

1 reference

14 January 2018

1 reference

5

1 reference

14 January 2018

author name string

Ilka B Fuchs

1

1 reference

14 January 2018

Solveig Landt

2

1 reference

14 January 2018

Helmut Bueler

3

1 reference

14 January 2018

Uwe Kuehl

4

1 reference

14 January 2018

Anke Kleine-Tebbe

6

1 reference

14 January 2018

Werner Lichtenegger

7

1 reference

14 January 2018

Gerhard Schaller

8

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 November 2003

1 reference

14 January 2018

Breast Cancer Research and Treatment

published in

1 reference

14 January 2018

volume

82

1 reference

14 January 2018

page(s)

23-28

1 reference

14 January 2018

issue

1

1 reference

14 January 2018

https://scigraph.springernature.com/pub.10.1023/b:brea.0000003916.39959.73

exact match

0 references

cites work

Trastuzumab in the treatment of metastatic breast cancer : anticancer therapy versus cardiotoxicity

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

Expression of the ERBB3 gene product in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

Neuregulin in Cardiac Hypertrophy in Rats With Aortic Stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Trastuzumab therapy and the heart: palliation at what cost?

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Requirement for neuregulin receptor erbB2 in neural and cardiac development

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Stress pathways and heart failure

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

neu tack on neuregulin

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

ErbB2 is essential in the prevention of dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003916.39959.73

7 January 2021

10.1023/B:BREA.0000003916.39959.73

Identifiers

DOI

1 reference

14 January 2018

Dimensions Publication ID

1024652718

0 references

Fatcat ID

release_tkzvseudb5dpzbl4hcn3spjq64

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tkzvseudb5dpzbl4hcn3spjq64

24 November 2022

mapped directly with Wikidata item

PubMed ID

14672400

1 reference

14 January 2018